Potential Associations between Vascular Biology and Hodgkin's Lymphoma: An Overview.
Hodgkin’s disease
animal models
blood vessels
cell biology
targeted therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
06 Nov 2023
06 Nov 2023
Historique:
received:
24
08
2023
revised:
24
10
2023
accepted:
03
11
2023
medline:
14
11
2023
pubmed:
14
11
2023
entrez:
14
11
2023
Statut:
epublish
Résumé
Hodgkin's lymphoma (HL) is a lymphatic neoplasm typically found in the cervical lymph nodes. The disease is multifactorial, and in recent years, the relationships between various vascular molecules have been explored in the field of vascular biology. The connection between vascular biology and HL is intricate and the roles of several pathways remain unclear. This review summarizes the cellular and molecular relationships between vascular biology and HL. Proteins associated with various functions in vascular biology, including cytokines (TNF-α, IL-1, IL-13, and IL-21), chemokines (CXCL10, CXCL12, and CCL21), adhesion molecules (ELAM-1/VCAM-1), and growth factors (BDNF/NT-3, platelet-derived growth factor receptor-α), have been linked to tumor activity. Notable tumor activities include the induction of paracrine activation of NF-kB-dependent pathways, upregulation of adhesion molecule regulation, genome amplification, and effective loss of antigen presentation mediated by MHC-II. Preclinical study models, primarily those using cell culture, have been optimized for HL. Animal models, particularly mice, are also used as alternatives to complex biological systems, with studies primarily focusing on the physiopathogenic evaluation of the disease. These biomolecules warrant further study because they may shed light on obscure pathways and serve as targets for prevention and/or treatment interventions.
Identifiants
pubmed: 37958472
pii: cancers15215299
doi: 10.3390/cancers15215299
pmc: PMC10649902
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Drug Des Devel Ther. 2020 May 04;14:1693-1704
pubmed: 32440095
Cancer Immunol Immunother. 2009 Jan;58(1):85-94
pubmed: 18488221
Blood. 2014 Nov 6;124(19):2973-82
pubmed: 25139349
Mol Cell Ther. 2014 Sep 10;2:27
pubmed: 26056594
Cureus. 2023 Jul 10;15(7):e41660
pubmed: 37565112
Blood Adv. 2022 Feb 22;6(4):1255-1263
pubmed: 34666347
Semin Oncol Nurs. 2019 Oct;35(5):150923
pubmed: 31526550
J Immunol Res. 2021 Feb 22;2021:6661406
pubmed: 33681388
Blood. 2019 Aug 15;134(7):591-596
pubmed: 31186275
Nat Rev Cancer. 2017 Apr;17(4):209-222
pubmed: 28233802
Front Immunol. 2021 Apr 16;12:672356
pubmed: 33936118
Am J Pathol. 1991 Oct;139(4):701-7
pubmed: 1656757
Cancers (Basel). 2023 Mar 24;15(7):
pubmed: 37046617
Front Immunol. 2020 Dec 03;11:591741
pubmed: 33343570
Curr Opin Biotechnol. 2022 Apr;74:8-14
pubmed: 34749063
Lab Invest. 2007 Apr;87(4):372-82
pubmed: 17310217
Int J Mol Sci. 2019 Nov 05;20(21):
pubmed: 31694167
Annu Rev Immunol. 1998;16:471-93
pubmed: 9597138
Cancers (Basel). 2021 Nov 12;13(22):
pubmed: 34830831
Cancers (Basel). 2021 Dec 28;14(1):
pubmed: 35008305
J Natl Cancer Inst. 1991 Dec 18;83(24):1797-805
pubmed: 1683908
Int J Mol Sci. 2022 Mar 26;23(7):
pubmed: 35409010
Semin Cancer Biol. 2023 Jun;91:50-69
pubmed: 36870459
Br J Pharmacol. 1997 Oct;122(4):749-57
pubmed: 9375973
Cell Commun Signal. 2022 Nov 23;20(1):186
pubmed: 36419156
Cancer Lett. 2021 Mar 1;500:182-193
pubmed: 33326840
Cancers (Basel). 2022 Mar 07;14(5):
pubmed: 35267668
Cancers (Basel). 2022 Sep 01;14(17):
pubmed: 36077832
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2737-47
pubmed: 25205514
Cell Prolif. 2020 Jan;53(1):e12712
pubmed: 31730279
J Allergy Clin Immunol. 2016 Oct;138(4):984-1010
pubmed: 27577879
Leuk Lymphoma. 2022 Aug;63(8):1871-1878
pubmed: 35848865
Front Immunol. 2023 Feb 09;14:1113312
pubmed: 36845095
Cancers (Basel). 2021 Jul 18;13(14):
pubmed: 34298810
Clin Dev Immunol. 2012;2012:756353
pubmed: 22927872
Int J Biochem Cell Biol. 2005 Mar;37(3):511-7
pubmed: 15618006
Biochim Biophys Acta Rev Cancer. 2023 Jan;1878(1):188845
pubmed: 36476563
Cancers (Basel). 2022 Mar 25;14(7):
pubmed: 35406451
Eur J Haematol. 2022 Dec;109(6):728-735
pubmed: 36056778
Blood Rev. 2022 Sep;55:100949
pubmed: 35396126
Am J Surg Pathol. 1999 Oct;23(10):1233-40
pubmed: 10524524
J Clin Invest. 2017 Sep 1;127(9):3462-3471
pubmed: 28805662
J Biol Chem. 1994 Feb 4;269(5):3139-42
pubmed: 8106347
Leuk Lymphoma. 2018 Feb;59(2):357-362
pubmed: 28597723
Front Oncol. 2022 Nov 10;12:944511
pubmed: 36439517
Reprod Biomed Online. 2021 Dec;43(6):1045-1056
pubmed: 34627683
Clin Cancer Res. 2017 Mar 1;23(5):1156-1166
pubmed: 27582488
J Immunother Cancer. 2023 Mar;11(3):
pubmed: 36948506
J Clin Oncol. 2010 May 20;28(15):2625-34
pubmed: 20404250
Nat Rev Drug Discov. 2018 Dec;17(12):887-904
pubmed: 30361552
Circulation. 2016 Jun 21;133(25):2603-9
pubmed: 27324355
J Immunother Cancer. 2022 May;10(5):
pubmed: 35584865
Sci Rep. 2020 Jun 10;10(1):9410
pubmed: 32523087
Cancers (Basel). 2020 Apr 04;12(4):
pubmed: 32260340
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Expert Rev Mol Diagn. 2007 Nov;7(6):805-20
pubmed: 18020910
N Engl J Med. 2022 Nov 3;387(18):1649-1660
pubmed: 36322844
Cancers (Basel). 2021 Jul 20;13(14):
pubmed: 34298847
Cancers (Basel). 2023 Jun 20;15(12):
pubmed: 37370872
Front Oncol. 2018 Jul 27;8:288
pubmed: 30101129
Am J Transl Res. 2020 Nov 15;12(11):7034-7047
pubmed: 33312349
Exp Hematol. 2013 Dec;41(12):995-1004
pubmed: 24099823
Cells. 2023 Jul 05;12(13):
pubmed: 37443818
Brief Funct Genomics. 2020 May 20;19(3):175-182
pubmed: 31950135
Pathol Res Pract. 2023 Sep;249:154739
pubmed: 37544129
Pediatr Blood Cancer. 2012 Aug;59(2):285-9
pubmed: 22457206
Biomed Res Int. 2018 Jun 10;2018:3261436
pubmed: 29984229
Br J Haematol. 2022 Sep;198(5):847-860
pubmed: 35819919
Nat Rev Drug Discov. 2014 May;13(5):379-95
pubmed: 24751819
Nanomedicine (Lond). 2021 Dec;16(29):2633-2650
pubmed: 34854309
Leukemia. 2014 Nov;28(11):2248-51
pubmed: 24947018
Haematologica. 2019 Mar;104(3):564-575
pubmed: 30309853
Nat Rev Dis Primers. 2021 Oct 20;7(1):79
pubmed: 34671052
J Pathol. 2010 Jul;221(3):248-63
pubmed: 20527019
Pharmaceutics. 2023 Jan 03;15(1):
pubmed: 36678793
Autoimmun Rev. 2004 Feb;3(2):69-75
pubmed: 15003190
Nature. 2011 Mar 17;471(7338):377-81
pubmed: 21368758
Biomolecules. 2023 May 27;13(6):
pubmed: 37371477
Cancer Rep (Hoboken). 2021 Apr;4(2):e1311
pubmed: 33103852
Leukemia. 2022 Mar;36(3):760-771
pubmed: 34584203
Blood Coagul Fibrinolysis. 2021 Jun 1;32(4):266-272
pubmed: 33955861
Biomaterials. 2021 May;272:120791
pubmed: 33831739
Blood. 1996 Aug 15;88(4):1457-64
pubmed: 8695866
Health Sci Rep. 2023 Feb 05;6(2):e1085
pubmed: 36778773
Front Oncol. 2023 May 24;13:1203470
pubmed: 37293587
J Cell Physiol. 2019 Feb;234(2):1313-1325
pubmed: 30191996
EMBO J. 1997 May 15;16(10):2851-60
pubmed: 9184229
Clin Cancer Res. 2011 Oct 15;17(20):6428-36
pubmed: 22003070
Cells. 2019 Nov 27;8(12):
pubmed: 31783588
Lancet. 2003 Mar 15;361(9361):943-51
pubmed: 12648984
Tissue Antigens. 2009 Dec;74(6):467-79
pubmed: 19845910
Exp Hematol. 2002 May;30(5):450-9
pubmed: 12031651
Cancer Lett. 2016 Aug 10;378(2):150-9
pubmed: 27224890
Antiinflamm Antiallergy Agents Med Chem. 2021;20(4):317-332
pubmed: 34544350
Annu Rev Pathol. 2009;4:151-74
pubmed: 19400691
J Pathol. 2015 Jan;235(2):312-22
pubmed: 25294567
N Engl J Med. 2022 Jul 28;387(4):310-320
pubmed: 35830649
Front Immunol. 2022 Oct 20;13:954992
pubmed: 36341428
Blood. 2010 Jul 22;116(3):418-27
pubmed: 20339089
Mol Immunol. 2022 Dec;152:55-66
pubmed: 36279659
Int J Mol Sci. 2019 May 15;20(10):
pubmed: 31096713
Curr Opin Pharmacol. 2021 Dec;61:49-61
pubmed: 34619442
Nat Rev Cancer. 2008 Jun;8(6):473-80
pubmed: 18469827
JAMA Oncol. 2023 May 1;9(5):683-691
pubmed: 36928527
Hemasphere. 2021 Sep 01;5(9):e633
pubmed: 34485830
J Clin Pathol. 2002 Mar;55(3):162-76
pubmed: 11896065
Int J Mol Sci. 2023 Apr 24;24(9):
pubmed: 37175487
Oncologist. 2001;6 Suppl 5:32-9
pubmed: 11700390
Cancer Sci. 2021 Jul;112(7):2592-2606
pubmed: 33938090
Blood. 2002 Jun 15;99(12):4283-97
pubmed: 12036854
J Immunol. 1995 Jan 15;154(2):799-803
pubmed: 7529288
Biol Blood Marrow Transplant. 2019 Sep;25(9):1713-1719
pubmed: 31170519
Cancers (Basel). 2023 May 17;15(10):
pubmed: 37345141
Leuk Lymphoma. 2019 Dec;60(14):3434-3441
pubmed: 31318305
Int J Mol Sci. 2019 Dec 16;20(24):
pubmed: 31888191
Cold Spring Harb Perspect Med. 2020 Jun 1;10(6):
pubmed: 31727680
J Physiol. 2021 Jan;599(1):23-37
pubmed: 33006160
Expert Rev Hematol. 2021 Sep;14(9):867-875
pubmed: 34275403
J Pers Med. 2022 Feb 01;12(2):
pubmed: 35207685
Cancer Lett. 2016 Sep 28;380(1):243-52
pubmed: 26474544
Trends Immunol. 2012 Mar;33(3):144-52
pubmed: 22169337
Blood. 2015 Feb 12;125(7):1061-72
pubmed: 25488972
Cancers (Basel). 2020 Nov 04;12(11):
pubmed: 33158258
Cancer Treat Rev. 2020 Jan;82:101931
pubmed: 31756590
Cancers (Basel). 2020 Jan 14;12(1):
pubmed: 31947626
Semin Cancer Biol. 2014 Feb;24:15-22
pubmed: 23867303
J Hematol Oncol. 2022 May 11;15(1):57
pubmed: 35546241
Cell Oncol (Dordr). 2019 Oct;42(5):591-608
pubmed: 31144271
Leuk Lymphoma. 2022 May;63(5):1080-1090
pubmed: 34957890
Int Immunol. 2016 Aug;28(8):373-82
pubmed: 27121213
Thromb Res. 2000 Nov 1;100(3):211-21
pubmed: 11108908
Cancers (Basel). 2021 Feb 20;13(4):
pubmed: 33672548
Nat Immunol. 2007 Mar;8(3):239-45
pubmed: 17304234
J Clin Invest. 2012 Oct;122(10):3439-47
pubmed: 23023715
J Clin Oncol. 2018 Apr 1;36(10):942-950
pubmed: 29394125
Nat Rev Cancer. 2014 Aug;14(8):517-34
pubmed: 25008267
Int Immunopharmacol. 2022 Nov;112:109235
pubmed: 36215869
Leukemia. 2021 Apr;35(4):968-981
pubmed: 33686198
Front Immunol. 2023 Aug 21;14:1203073
pubmed: 37671162
Blood Adv. 2022 Jan 25;6(2):590-599
pubmed: 34644372
Anal Chem. 2010 Jul 15;82(14):6237-43
pubmed: 20565106
J Pathol. 1993 Oct;171(2):131-6
pubmed: 7506770
Lancet Haematol. 2023 Jan;10(1):e14-e23
pubmed: 36403579
Cytokine. 2000 Mar;12(3):246-52
pubmed: 10704252
J Clin Oncol. 2020 Nov 10;38(32):3794-3804
pubmed: 32701411
Semin Oncol. 2008 Oct;35(5):484-93
pubmed: 18929147
Cancer Commun (Lond). 2022 Nov;42(11):1112-1140
pubmed: 36069342
Nat Rev Cancer. 2009 Jan;9(1):15-27
pubmed: 19078975
Cancer Lett. 2022 Sep 1;543:215766
pubmed: 35690285
Cancers (Basel). 2022 Jun 14;14(12):
pubmed: 35740598
Apoptosis. 2023 Feb;28(1-2):20-38
pubmed: 36342579
Genes Dev. 2008 May 15;22(10):1276-312
pubmed: 18483217
Am J Epidemiol. 2010 Feb 1;171(3):267-76
pubmed: 20047977
J Immunol. 1988 Jan 15;140(2):679-87
pubmed: 3275720